| Q1 revenue | $5.4B | CFO |
| Q1 revenue growth (constant currency) | +3.9% YoY | CFO |
| Financial Services segment growth (constant currency) | >10% YoY | CFO |
| Q1 bookings growth | +21% YoY | CEO, CFO |
| Large deals ≥$100M signed in Q1 | 7 | CEO, CFO |
| Mega deal ≥$500M signed in Q1 | 1 | CEO, CFO |
| Trailing 12-month book-to-bill | 1.4 | CFO |
| Q1 adjusted operating margin | 15.6% (+10 bps YoY) | CFO |
| Q1 gross margin change | -80 bps YoY | CFO |
| Q1 adjusted diluted EPS | $1.40 (+14% YoY) | CFO |
| Q1 free cash flow | ~$200M | CFO |
| Cash and short-term investments | $1.5B | CFO |
| Net cash | $949M | CFO |
| Q1 DSO | 84 days | CFO |
| AI engagements | >5,000 (up from ~4,000 exiting Dec) | CEO |
| AI-assisted code | ~40% | CEO |
| Total U.S. AI Lab patents | 65 | CEO |
| Total global AI Lab patents | 88 | CEO |
| 2026 fresher hires | >20,000 (2025 baseline; plan to hire greater number in 2026) | CEO |
| Project LEAP 2026 pre-tax savings | $200–$300M | CFO |
| Project LEAP expected 2026 costs | $230–$320M (employee severance: $200–$270M; other: $30–$50M) | CFO |
| 2026 adjusted operating margin guidance | 16.0%–16.2% | CFO |
| 2026 adjusted EPS guidance | $5.63–$5.77 | CFO |
| 2026 free cash flow conversion guidance | 90%–100% of net income | CFO |
| 2026 tax rate guidance | 25%–26% | CFO |
| 2026 expected diluted share count | ~473M | CFO |
| 2026 capital return target | ~$1.6B ($1B repurchases + dividend) | CFO |
| Trailing 12-month revenue per employee | +2.5% | CEO |
| Trailing 12-month adjusted operating margin per employee | +5% | CEO |